Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurofibromatosis 2 | 6 | 2023 | 381 | 2.680 |
Why?
|
Neuroma, Acoustic | 5 | 2020 | 449 | 1.980 |
Why?
|
Hearing Loss | 3 | 2021 | 759 | 1.240 |
Why?
|
Neurilemmoma | 4 | 2023 | 546 | 0.940 |
Why?
|
Pregnancy Proteins | 4 | 2013 | 229 | 0.920 |
Why?
|
Vascular Endothelial Growth Factor A | 12 | 2017 | 3504 | 0.910 |
Why?
|
Ascites | 2 | 2019 | 342 | 0.910 |
Why?
|
Neovascularization, Pathologic | 13 | 2019 | 2639 | 0.860 |
Why?
|
Losartan | 3 | 2023 | 284 | 0.800 |
Why?
|
Lymphokines | 4 | 2011 | 950 | 0.690 |
Why?
|
Cerebellopontine Angle | 1 | 2019 | 55 | 0.670 |
Why?
|
Neurofibromin 2 | 5 | 2023 | 267 | 0.640 |
Why?
|
Receptors, CXCR4 | 3 | 2011 | 726 | 0.590 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2017 | 123 | 0.570 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2011 | 625 | 0.540 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2018 | 578 | 0.470 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 1997 | 0.470 |
Why?
|
Neuropilin-1 | 2 | 2013 | 91 | 0.450 |
Why?
|
Stromal Cells | 1 | 2019 | 1350 | 0.450 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18003 | 0.410 |
Why?
|
Neoplasms, Experimental | 4 | 2016 | 1280 | 0.390 |
Why?
|
Chemokine CXCL12 | 2 | 2011 | 462 | 0.380 |
Why?
|
Rectal Neoplasms | 2 | 2010 | 1192 | 0.380 |
Why?
|
Neoplasm Proteins | 3 | 2017 | 3694 | 0.370 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2019 | 3562 | 0.370 |
Why?
|
Chemokine CXCL6 | 1 | 2009 | 13 | 0.360 |
Why?
|
Glioblastoma | 7 | 2023 | 3431 | 0.350 |
Why?
|
Central Nervous System Neoplasms | 1 | 2017 | 894 | 0.340 |
Why?
|
Antineoplastic Agents | 6 | 2019 | 13635 | 0.330 |
Why?
|
Doxorubicin | 2 | 2012 | 2218 | 0.330 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 4815 | 0.320 |
Why?
|
Cell Line, Tumor | 15 | 2021 | 16646 | 0.310 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2004 | 1285 | 0.310 |
Why?
|
Mice | 30 | 2024 | 81002 | 0.290 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2007 | 215 | 0.290 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2727 | 0.270 |
Why?
|
Ribonuclease, Pancreatic | 2 | 2016 | 153 | 0.260 |
Why?
|
Angiogenesis Inhibitors | 5 | 2011 | 2037 | 0.260 |
Why?
|
DNA Methylation | 2 | 2010 | 4269 | 0.250 |
Why?
|
Antibodies, Neoplasm | 2 | 2016 | 287 | 0.250 |
Why?
|
Hearing | 2 | 2019 | 478 | 0.250 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3497 | 0.240 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2005 | 188 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2019 | 8400 | 0.240 |
Why?
|
Animals | 36 | 2024 | 168368 | 0.240 |
Why?
|
Sciatic Nerve | 2 | 2017 | 611 | 0.220 |
Why?
|
Ubiquitination | 1 | 2007 | 1003 | 0.220 |
Why?
|
Mice, Nude | 5 | 2017 | 3692 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2007 | 984 | 0.210 |
Why?
|
DNA, Neoplasm | 1 | 2007 | 1754 | 0.210 |
Why?
|
Signal Transduction | 12 | 2018 | 23355 | 0.200 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 42 | 0.200 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2007 | 1331 | 0.200 |
Why?
|
Luciferases | 2 | 2019 | 734 | 0.200 |
Why?
|
Nerve Regeneration | 2 | 2017 | 795 | 0.190 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2021 | 191 | 0.190 |
Why?
|
Benzamides | 2 | 2020 | 1374 | 0.190 |
Why?
|
Endothelial Growth Factors | 2 | 2002 | 695 | 0.180 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 489 | 0.180 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3508 | 0.180 |
Why?
|
Rodentia | 1 | 2021 | 260 | 0.180 |
Why?
|
Cerebellar Neoplasms | 2 | 2016 | 582 | 0.170 |
Why?
|
Carcinoma, Renal Cell | 2 | 2024 | 3101 | 0.170 |
Why?
|
Lymph Nodes | 1 | 2011 | 3454 | 0.170 |
Why?
|
Cell Proliferation | 3 | 2012 | 10455 | 0.170 |
Why?
|
Medulloblastoma | 2 | 2016 | 677 | 0.170 |
Why?
|
Carcinoma | 1 | 2011 | 2361 | 0.170 |
Why?
|
Genes, Reporter | 2 | 2019 | 1549 | 0.170 |
Why?
|
Injections, Intraventricular | 1 | 2019 | 232 | 0.170 |
Why?
|
Virus Assembly | 1 | 2019 | 145 | 0.170 |
Why?
|
Granuloma | 2 | 2024 | 313 | 0.160 |
Why?
|
Hearing Tests | 1 | 2019 | 122 | 0.160 |
Why?
|
Cerebellum | 2 | 2017 | 1515 | 0.160 |
Why?
|
MAP Kinase Signaling System | 2 | 2004 | 1522 | 0.160 |
Why?
|
Promoter Regions, Genetic | 2 | 2007 | 5863 | 0.160 |
Why?
|
Kidney Neoplasms | 2 | 2024 | 4189 | 0.160 |
Why?
|
Binding, Competitive | 1 | 2019 | 1158 | 0.160 |
Why?
|
Neoplasm Transplantation | 4 | 2013 | 2084 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11410 | 0.150 |
Why?
|
Blood Vessels | 4 | 2015 | 1126 | 0.150 |
Why?
|
Probiotics | 1 | 2021 | 350 | 0.150 |
Why?
|
Tuberculosis | 2 | 2024 | 1892 | 0.150 |
Why?
|
Antibodies, Monoclonal | 4 | 2009 | 9259 | 0.150 |
Why?
|
Oxytocin | 1 | 2021 | 395 | 0.150 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3614 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 4 | 2010 | 545 | 0.140 |
Why?
|
Morpholines | 1 | 2020 | 562 | 0.140 |
Why?
|
Cell Cycle Proteins | 2 | 2007 | 3433 | 0.140 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2001 | 2558 | 0.140 |
Why?
|
Fluorescence | 1 | 2019 | 751 | 0.140 |
Why?
|
Stereotaxic Techniques | 1 | 2019 | 535 | 0.140 |
Why?
|
Edema | 2 | 2023 | 791 | 0.140 |
Why?
|
Rotarod Performance Test | 1 | 2015 | 63 | 0.140 |
Why?
|
Capsid Proteins | 1 | 2019 | 479 | 0.140 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2021 | 740 | 0.130 |
Why?
|
Organ Culture Techniques | 1 | 2018 | 813 | 0.130 |
Why?
|
Granuloma, Respiratory Tract | 1 | 2015 | 8 | 0.130 |
Why?
|
Colonic Neoplasms | 1 | 2007 | 2530 | 0.130 |
Why?
|
Cerebellar Diseases | 1 | 2017 | 226 | 0.130 |
Why?
|
Cell Growth Processes | 2 | 2006 | 399 | 0.130 |
Why?
|
Apoptosis | 5 | 2012 | 9714 | 0.130 |
Why?
|
Cell Hypoxia | 1 | 2017 | 676 | 0.130 |
Why?
|
Meningioma | 1 | 2023 | 1202 | 0.120 |
Why?
|
Drug Synergism | 1 | 2019 | 1792 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2015 | 1214 | 0.120 |
Why?
|
Breast Neoplasms | 2 | 2012 | 20676 | 0.120 |
Why?
|
Meningeal Neoplasms | 1 | 2023 | 1234 | 0.120 |
Why?
|
Second Messenger Systems | 1 | 2015 | 206 | 0.120 |
Why?
|
Mice, SCID | 7 | 2017 | 2716 | 0.120 |
Why?
|
Humans | 39 | 2024 | 739398 | 0.120 |
Why?
|
Mice, Knockout | 7 | 2021 | 14558 | 0.120 |
Why?
|
Pyrimidines | 2 | 2020 | 2918 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2004 | 2933 | 0.120 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2015 | 877 | 0.120 |
Why?
|
Antibodies, Bispecific | 1 | 2016 | 164 | 0.120 |
Why?
|
Transfection | 4 | 2006 | 5884 | 0.120 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1374 | 0.120 |
Why?
|
Antibodies | 3 | 2015 | 2450 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2009 | 3922 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 953 | 0.110 |
Why?
|
Vesicular Transport Proteins | 1 | 2016 | 371 | 0.110 |
Why?
|
Radiation Tolerance | 1 | 2015 | 486 | 0.110 |
Why?
|
Mycobacterium tuberculosis | 1 | 2024 | 1819 | 0.110 |
Why?
|
Treatment Outcome | 6 | 2022 | 62693 | 0.110 |
Why?
|
Disease Progression | 6 | 2017 | 13237 | 0.110 |
Why?
|
Radiotherapy | 2 | 2018 | 1526 | 0.110 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5830 | 0.110 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 664 | 0.110 |
Why?
|
Muscular Atrophy | 1 | 2015 | 346 | 0.110 |
Why?
|
Lymphatic Metastasis | 2 | 2011 | 2897 | 0.110 |
Why?
|
Blotting, Western | 3 | 2012 | 5181 | 0.110 |
Why?
|
Osteoarthritis, Knee | 1 | 2022 | 1218 | 0.100 |
Why?
|
Oxygen | 4 | 2024 | 4158 | 0.100 |
Why?
|
Macrophages | 2 | 2016 | 5631 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1405 | 0.100 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2012 | 313 | 0.100 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1734 | 0.100 |
Why?
|
Receptors, CXCR | 1 | 2011 | 53 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5148 | 0.100 |
Why?
|
Brain Neoplasms | 4 | 2010 | 8791 | 0.100 |
Why?
|
Cyclic AMP | 1 | 2015 | 1470 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2102 | 0.090 |
Why?
|
Collagen | 1 | 2019 | 2671 | 0.090 |
Why?
|
Prognosis | 4 | 2019 | 28901 | 0.090 |
Why?
|
Lung Neoplasms | 3 | 2012 | 12985 | 0.090 |
Why?
|
Basement Membrane | 2 | 2008 | 356 | 0.090 |
Why?
|
Lymphangiogenesis | 1 | 2011 | 170 | 0.090 |
Why?
|
Collagen Type I | 1 | 2012 | 577 | 0.090 |
Why?
|
Quinazolines | 1 | 2016 | 1356 | 0.090 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2015 | 806 | 0.080 |
Why?
|
Lamins | 1 | 2008 | 36 | 0.080 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 689 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1599 | 0.080 |
Why?
|
Angiopoietin-1 | 2 | 2005 | 114 | 0.080 |
Why?
|
Tissue Distribution | 1 | 2012 | 2345 | 0.080 |
Why?
|
Tumor Stem Cell Assay | 1 | 2007 | 117 | 0.080 |
Why?
|
Pia Mater | 1 | 2008 | 88 | 0.080 |
Why?
|
Phthalazines | 1 | 2010 | 357 | 0.080 |
Why?
|
Gene Expression | 3 | 2019 | 7788 | 0.080 |
Why?
|
Rabbits | 3 | 2024 | 4882 | 0.080 |
Why?
|
Leupeptins | 1 | 2007 | 122 | 0.080 |
Why?
|
DNA Damage | 1 | 2018 | 2419 | 0.080 |
Why?
|
Paracrine Communication | 2 | 2013 | 276 | 0.080 |
Why?
|
Nitric Oxide | 2 | 2008 | 2121 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 2986 | 0.080 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2007 | 191 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2017 | 1621 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2503 | 0.070 |
Why?
|
Tumor Burden | 1 | 2012 | 1904 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3609 | 0.070 |
Why?
|
Immunoenzyme Techniques | 1 | 2009 | 1801 | 0.070 |
Why?
|
Trophoblasts | 1 | 2007 | 214 | 0.070 |
Why?
|
Immunohistochemistry | 3 | 2011 | 11347 | 0.070 |
Why?
|
Disease | 1 | 2011 | 683 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 3863 | 0.070 |
Why?
|
Capillary Permeability | 2 | 2006 | 799 | 0.060 |
Why?
|
HCT116 Cells | 1 | 2006 | 409 | 0.060 |
Why?
|
Extracellular Fluid | 1 | 2006 | 166 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5460 | 0.060 |
Why?
|
Dimerization | 1 | 2006 | 892 | 0.060 |
Why?
|
Transplantation, Heterologous | 3 | 2013 | 2381 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 10961 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4743 | 0.060 |
Why?
|
Genes, Dominant | 2 | 2004 | 883 | 0.060 |
Why?
|
Interleukin-8 | 2 | 2004 | 685 | 0.060 |
Why?
|
DNA, Complementary | 1 | 2007 | 2049 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5502 | 0.060 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2002 | 773 | 0.060 |
Why?
|
Cell Movement | 4 | 2015 | 5221 | 0.060 |
Why?
|
Female | 10 | 2021 | 378853 | 0.060 |
Why?
|
MicroRNAs | 1 | 2019 | 3712 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2012 | 1957 | 0.050 |
Why?
|
Up-Regulation | 2 | 2009 | 4205 | 0.050 |
Why?
|
Ubiquitin | 1 | 2007 | 847 | 0.050 |
Why?
|
Models, Biological | 3 | 2015 | 9609 | 0.050 |
Why?
|
Down-Regulation | 2 | 2007 | 2999 | 0.050 |
Why?
|
Blotting, Northern | 1 | 2004 | 1583 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2005 | 637 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2019 | 6610 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6726 | 0.050 |
Why?
|
Lactobacillus plantarum | 1 | 2021 | 5 | 0.050 |
Why?
|
Melanoma, Experimental | 1 | 2005 | 562 | 0.050 |
Why?
|
Lymphatic Vessels | 1 | 2006 | 352 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2009 | 13002 | 0.050 |
Why?
|
HIV-1 | 1 | 2019 | 6931 | 0.050 |
Why?
|
Glioma | 2 | 2008 | 3378 | 0.050 |
Why?
|
DNA Primers | 2 | 2003 | 2893 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 691 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2022 | 10945 | 0.050 |
Why?
|
Receptor, EphA1 | 1 | 2020 | 20 | 0.050 |
Why?
|
Piperazines | 1 | 2011 | 2480 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 480 | 0.050 |
Why?
|
Neovascularization, Physiologic | 2 | 2005 | 1352 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2011 | 2220 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2004 | 7709 | 0.040 |
Why?
|
Cell Line | 2 | 2019 | 15987 | 0.040 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2002 | 522 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2006 | 966 | 0.040 |
Why?
|
Pyridines | 1 | 2010 | 2810 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 2 | 2013 | 551 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 423 | 0.040 |
Why?
|
Neurofibromatoses | 1 | 2022 | 299 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2007 | 1849 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9387 | 0.040 |
Why?
|
Pericytes | 2 | 2015 | 291 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2022 | 11985 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 56255 | 0.040 |
Why?
|
Receptor, TIE-2 | 2 | 2010 | 178 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8605 | 0.040 |
Why?
|
Neoplasms | 3 | 2011 | 21507 | 0.040 |
Why?
|
Prospective Studies | 1 | 2021 | 53037 | 0.040 |
Why?
|
Capsid | 1 | 2019 | 435 | 0.040 |
Why?
|
Protein Kinases | 1 | 2004 | 1637 | 0.040 |
Why?
|
Adipocytes | 1 | 2003 | 1171 | 0.040 |
Why?
|
RNA Interference | 1 | 2005 | 2899 | 0.030 |
Why?
|
Enzyme Inhibitors | 2 | 2005 | 3802 | 0.030 |
Why?
|
Respiratory Transport | 1 | 2015 | 7 | 0.030 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2017 | 268 | 0.030 |
Why?
|
Adolescent | 3 | 2021 | 85405 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2005 | 3498 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2006 | 4832 | 0.030 |
Why?
|
Analgesics | 1 | 2022 | 1034 | 0.030 |
Why?
|
Male | 10 | 2021 | 349022 | 0.030 |
Why?
|
Pharmacology, Clinical | 1 | 2015 | 20 | 0.030 |
Why?
|
Feces | 1 | 2021 | 1389 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 21863 | 0.030 |
Why?
|
Skin Neoplasms | 2 | 2022 | 5632 | 0.030 |
Why?
|
Pharmacology | 1 | 2015 | 103 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2021 | 1348 | 0.030 |
Why?
|
International Agencies | 1 | 2015 | 240 | 0.030 |
Why?
|
Base Sequence | 2 | 2003 | 12804 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2021 | 1822 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4216 | 0.030 |
Why?
|
Societies, Scientific | 1 | 2015 | 220 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6310 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 2845 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3193 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2021 | 76631 | 0.030 |
Why?
|
Pain Measurement | 1 | 2022 | 3419 | 0.030 |
Why?
|
Phosphorylation | 1 | 2004 | 8416 | 0.030 |
Why?
|
Coloring Agents | 1 | 2015 | 564 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2277 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1890 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2016 | 719 | 0.030 |
Why?
|
Quality of Life | 2 | 2024 | 12640 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2008 | 5721 | 0.030 |
Why?
|
Hedgehog Proteins | 1 | 2016 | 774 | 0.020 |
Why?
|
Virus Replication | 1 | 2019 | 2529 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1643 | 0.020 |
Why?
|
Brain | 1 | 2018 | 26345 | 0.020 |
Why?
|
beta Catenin | 1 | 2016 | 1057 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2728 | 0.020 |
Why?
|
Benzylamines | 1 | 2011 | 227 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1725 | 0.020 |
Why?
|
Heterocyclic Compounds | 1 | 2011 | 248 | 0.020 |
Why?
|
Lymphatic System | 1 | 2011 | 253 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6478 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4424 | 0.020 |
Why?
|
Middle Aged | 3 | 2018 | 212863 | 0.020 |
Why?
|
Adult | 3 | 2018 | 213394 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2010 | 888 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2015 | 3137 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8275 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2008 | 324 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2008 | 170 | 0.020 |
Why?
|
Ligands | 1 | 2015 | 3311 | 0.020 |
Why?
|
Dacarbazine | 1 | 2010 | 568 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2015 | 1548 | 0.020 |
Why?
|
Homeodomain Proteins | 2 | 2008 | 2409 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2003 | 11460 | 0.020 |
Why?
|
Hydrostatic Pressure | 1 | 2006 | 107 | 0.020 |
Why?
|
Cell Division | 2 | 2004 | 4575 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 997 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2003 | 5213 | 0.020 |
Why?
|
omega-N-Methylarginine | 1 | 2005 | 111 | 0.020 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2008 | 406 | 0.020 |
Why?
|
Ephrin-B2 | 1 | 2004 | 39 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2008 | 691 | 0.020 |
Why?
|
Cell Membrane | 1 | 2015 | 3747 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2008 | 562 | 0.020 |
Why?
|
Tubulin | 1 | 2008 | 696 | 0.020 |
Why?
|
Collagen Type IV | 1 | 2004 | 136 | 0.020 |
Why?
|
Diffusion Chambers, Culture | 1 | 2003 | 50 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2013 | 19220 | 0.010 |
Why?
|
Gamma Rays | 1 | 2004 | 321 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 331 | 0.010 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2006 | 482 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2004 | 276 | 0.010 |
Why?
|
Hyperplasia | 1 | 2006 | 1181 | 0.010 |
Why?
|
Neuroglia | 1 | 2008 | 928 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2008 | 2732 | 0.010 |
Why?
|
Dipeptides | 1 | 2004 | 409 | 0.010 |
Why?
|
Matrix Metalloproteinases | 1 | 2004 | 391 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 916 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 1698 | 0.010 |
Why?
|
3T3 Cells | 1 | 2003 | 1103 | 0.010 |
Why?
|
Genes, erbB-2 | 1 | 2002 | 162 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10142 | 0.010 |
Why?
|
Neutralization Tests | 1 | 2003 | 757 | 0.010 |
Why?
|
Proteoglycans | 1 | 2004 | 835 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2004 | 612 | 0.010 |
Why?
|
Gene Silencing | 1 | 2008 | 1537 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2010 | 1907 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2010 | 7862 | 0.010 |
Why?
|
Fluorescein Angiography | 1 | 2004 | 939 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 13880 | 0.010 |
Why?
|
Isoenzymes | 1 | 2004 | 1720 | 0.010 |
Why?
|
Antigens | 1 | 2004 | 1462 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 862 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4395 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6361 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 40802 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3615 | 0.010 |
Why?
|
Lung | 1 | 2015 | 9782 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2006 | 2936 | 0.010 |
Why?
|
NF-kappa B | 1 | 2004 | 2502 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2005 | 1869 | 0.010 |
Why?
|
Stem Cells | 1 | 2008 | 3566 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2003 | 1628 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2004 | 3194 | 0.010 |
Why?
|
Child | 1 | 2021 | 77033 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2005 | 3435 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20055 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 9375 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15500 | 0.010 |
Why?
|
Neurons | 1 | 2008 | 9336 | 0.010 |
Why?
|
Transcription Factors | 1 | 2003 | 12120 | 0.000 |
Why?
|
Mutation | 1 | 2008 | 29658 | 0.000 |
Why?
|
Time Factors | 1 | 2004 | 40050 | 0.000 |
Why?
|
Aged | 1 | 2010 | 162698 | 0.000 |
Why?
|